COEP
Coeptis Therapeutics Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.04
-0.03 ▼ -0.25%
🌙 3월 13일 6:09 PM ET (한국 3/14 07:09)
$12.28
+0.24 ▲ +1.99%
| Index | - | P/E | - | EPS (ttm) | -3.95 | Insider Own | 18.15% | Shs Outstand | 0.01B | Perf Week | -8.72% |
| Market Cap | 0.07B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 0.42% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | - | Inst Own | 8.07% | Short Float | 9.08% | Perf Quarter | -20% |
| Income | -0.01B | P/S | 138.76 | EPS this Y | - | Inst Trans | 16.89% | Short Ratio | 6.61 | Perf Half Y | -3.14% |
| Sales | 0.00B | P/B | 4.98 | EPS next 5Y | - | ROA | -90.3% | Short Interest | 0.43M | Perf YTD | -15.51% |
| Book/sh | 2.42 | P/C | 13.02 | EPS past 3/5Y | 38.79% -322.46% | ROE | -127.31% | 52W High | -43.76% ($21.41) | Perf Year | 15.22% |
| Cash/sh | 0.92 | P/FCF | - | Sales past 3/5Y | - | ROIC | -97.84% | 52W Low | 92.33% ($6.26) | Perf 3Y | -58.48% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.81% | Gross Margin | -592.22% | Volatility(W/M) | 10.86% 7.86% | Perf 5Y | -93.92% |
| Dividend TTM | - | EV/Sales | 129.76 | Sales Y/Y TTM | - | Oper. Margin | -2638.23% | ATR (14) | 1.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.21 | EPS Q/Q | 37.18% | Profit Margin | -2463.79% | RSI (14) | 45.96 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.21 | Sales Q/Q | - | SMA20 | -0.78% ($12.13) | Beta | -0.47 | Target Price | $80 |
| Payout | - | Debt/Eq | 0.02 | Earnings | - | SMA50 | -7.12% ($12.96) | Rel Volume | 1.06 | Prev Close | $12.07 |
| Employees | 7 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -7.39% ($13) | Avg Volume(3M) | 0.06M | Price | $12.04 |
| IPO | 2020/12/17 | Option/Short | No/Yes | Trades | 490 | Volume | 68,478 | Change | -0.25% |
뉴스 로딩 중...